HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keefe T Chan Selected Research

Breast Neoplasms (Breast Cancer)

12/2023INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors.
1/2019Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
1/2017The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer.
11/2015β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion.
4/2009FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion.
3/2008Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keefe T Chan Research Topics

Disease

13Neoplasms (Cancer)
12/2023 - 10/2014
6Breast Neoplasms (Breast Cancer)
12/2023 - 03/2008
3Melanoma (Melanoma, Malignant)
01/2019 - 10/2014
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2020
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
11/2020
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2017
1Neoplasm Metastasis (Metastasis)
11/2015
1Nevus (Nevi)
05/2015

Drug/Important Bio-Agent (IBA)

5CX 5461IBA
01/2021 - 08/2016
2CystathionineIBA
01/2022 - 01/2018
2RNA Polymerase I (Polymerase I, RNA)IBA
01/2021 - 11/2020
2Mechanistic Target of Rapamycin Complex 1IBA
01/2020 - 01/2016
1ChromatinIBA
12/2023
1Cyclin-Dependent Kinase 2IBA
12/2023
1Retinoblastoma ProteinIBA
12/2023
1DNA (Deoxyribonucleic Acid)IBA
11/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2019
1palbociclibIBA
01/2019
1Estrogen ReceptorsIBA
01/2019
1Cyclin-Dependent Kinase 4IBA
01/2019
1HomocysteineIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Ribosomal RNAIBA
01/2017
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2015
1Adrenergic Receptors (Adrenergic Receptor)IBA
11/2015
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2015
1Small Interfering RNA (siRNA)IBA
05/2015
1Monoclonal AntibodiesIBA
05/2015
1Formaldehyde (Formol)FDA Link
05/2015
1Interleukin-2 (IL2)IBA
05/2015
1ParaffinIBA
05/2015
1Proteins (Proteins, Gene)FDA Link
05/2015
1Messenger RNA (mRNA)IBA
05/2015
1emt protein-tyrosine kinase (IL2-inducible T-cell kinase)IBA
05/2015
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2014
1Tyrosine (L-Tyrosine)FDA Link
04/2009
1Focal Adhesion Protein-Tyrosine KinasesIBA
04/2009
1CalpainIBA
03/2008
1Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
03/2008

Therapy/Procedure

3Therapeutics
12/2023 - 11/2020